• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芝麻酚通过肝细胞与巨噬细胞之间的串扰,调节 FXR/LXR 轴介导线粒体自噬抑制作用,有望成为肝纤维化治疗的潜在候选药物。

Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage.

机构信息

Key Laboratory of Natural Medicines of the Changbai Mountain (Yanbian University), Ministry of Education, Key Laboratory for Traditional Chinese Korean Medicine Research (Yanbian University), State Ethnic Affairs, College of Pharmacy, Yanbian University, Yanji, Jilin Province 133002, China.

Air Force Medical University, Xi'an 710032, China.

出版信息

Phytomedicine. 2024 Jan;123:155145. doi: 10.1016/j.phymed.2023.155145. Epub 2023 Oct 13.

DOI:10.1016/j.phymed.2023.155145
PMID:37976698
Abstract

BACKGROUND

Sesamol (SEM), a natural lignan compound isolated from sesame, has strong anti-oxidant property, regulating lipid metabolism, decreasing cholesterol and hepatoprotection. However, its anti-hepatic fibrosis effect and mechanisms have not been comprehensively elucidated.

HYPOTHESIS/PURPOSE: This study aims to investigate the anti-hepatic fibrosis of SEM and its underlying mechanisms.

METHOD

C57BL/6 mice with hepatic fibrosis were induced by TAA, then administrated with SEM or curcumin, respectively. HSCs were stimulated by TGF-β or conditioned medium, and then cultured with SEM, GW4064, GW3965, Rapamycin (RA) or 3-methyladenine (3-MA), respectively. Mice with hepatic fibrosis also were administrated with SEM, RA or 3-MA to estimate the effect of SEM on autophagy.

RESULTS

In vitro, SEM significantly inhibited extracellular matrix deposition, P2 × 7r-NLRP3, and inflammatory cytokines. SEM increased FXR and LXRα/β expressions and decreased MAPLC3α/β and P62 expressions, functioning as 3-MA (autophagy inhibitor). In vivo, SEM reduced serum transaminase, histopathology changes, fibrogenesis, autophagy markers and inflammatory cytokines caused by TAA. LX-2 were activated with conditioned medium from LPS-primed THP-1, which resulted in significant enhance of autophagy markers and inflammatory cytokines and decrease of FXR and LXRα/β expressions. SEM could reverse above these changes and function as 3-MA, GW4064, or GW3965. Deficiency of FXR or LXR attenuated the regulation of SEM on α-SMA, MAPLC3α/β, P62 and IL-1β in activated LX-2. In activated THP-1, deficiency of FXR could decrease the expression of LXR, and vice versa. Deficiency of FXR or LXR in activated MΦ decreased the expressions of FXR and LXR in activated LX-2. Deficiency FXR or LXR in activated MΦ also attenuated the regulation of SEM on α-SMA, MAPLC3α/β, P62, caspase-1 and IL-1β. In vivo, SEM significantly reversed hepatic fibrosis via FXR/LXR and autophagy.

CONCLUSION

SEM could regulate hepatic fibrosis by inhibiting fibrogenesis, autophagy and inflammation. FXR/LXR axis-mediated inhibition of autophagy contributed to the regulation of SEM against hepatic fibrosis, especially based on involving in the crosstalk of HSCs-macrophage. SEM might be a prospective therapeutic candidate, and its mechanism would be a new direction or strategy for hepatic fibrosis treatment.

摘要

背景

芝麻酚(SEM)是一种从芝麻中分离出来的天然木脂素化合物,具有很强的抗氧化、调节脂质代谢、降低胆固醇和保肝作用。然而,其抗肝纤维化作用及其机制尚未得到全面阐明。

假说/目的:本研究旨在探讨 SEM 的抗肝纤维化作用及其机制。

方法

采用 TAA 诱导 C57BL/6 小鼠肝纤维化,分别给予 SEM 或姜黄素治疗。用 TGF-β或条件培养基刺激 HSCs,然后分别用 SEM、GW4064、GW3965、雷帕霉素(RA)或 3-甲基腺嘌呤(3-MA)培养。用 SEM、RA 或 3-MA 处理肝纤维化小鼠,以评估 SEM 对自噬的影响。

结果

体外实验中,SEM 显著抑制细胞外基质沉积、P2×7r-NLRP3 和炎症细胞因子。SEM 增加了 FXR 和 LXRα/β 的表达,降低了 MAPLC3α/β 和 P62 的表达,作用类似于 3-MA(自噬抑制剂)。体内实验中,SEM 降低了 TAA 引起的血清转氨酶、组织病理学改变、纤维化、自噬标志物和炎症细胞因子。用 LPS 预处理的 THP-1 条件培养基激活 LX-2,导致自噬标志物和炎症细胞因子显著增加,FXR 和 LXRα/β 表达减少。SEM 可以逆转这些变化,并作用类似于 3-MA、GW4064 或 GW3965。FXR 或 LXR 缺陷减弱了 SEM 对激活的 LX-2 中 α-SMA、MAPLC3α/β、P62 和 IL-1β 的调节作用。在激活的 THP-1 中,FXR 缺失可降低 LXR 的表达,反之亦然。在激活的 MΦ 中缺失 FXR 或 LXR 可降低激活的 LX-2 中 FXR 和 LXR 的表达。在激活的 MΦ 中缺失 FXR 或 LXR 也减弱了 SEM 对 α-SMA、MAPLC3α/β、P62、caspase-1 和 IL-1β 的调节作用。体内实验中,SEM 通过抑制纤维化、自噬和炎症显著逆转肝纤维化。

结论

SEM 可通过抑制纤维化、自噬和炎症来调节肝纤维化。FXR/LXR 轴介导的自噬抑制有助于 SEM 对肝纤维化的调节,特别是基于涉及 HSCs-巨噬细胞的串扰。SEM 可能是一种有前途的治疗候选药物,其机制将为肝纤维化治疗提供新的方向或策略。

相似文献

1
Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage.芝麻酚通过肝细胞与巨噬细胞之间的串扰,调节 FXR/LXR 轴介导线粒体自噬抑制作用,有望成为肝纤维化治疗的潜在候选药物。
Phytomedicine. 2024 Jan;123:155145. doi: 10.1016/j.phymed.2023.155145. Epub 2023 Oct 13.
2
Angelica dahurica extract and its effective component bergapten alleviated hepatic fibrosis by activating FXR signaling pathway.白芷提取物及其有效成分佛手柑内酯通过激活 FXR 信号通路缓解肝纤维化。
J Nat Med. 2024 Mar;78(2):427-438. doi: 10.1007/s11418-024-01780-8. Epub 2024 Feb 9.
3
Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling.覆盆子酮通过调节 FXR 和 PGC-1α 信号的串扰来减轻肝纤维化和炎症。
J Agric Food Chem. 2024 Jul 17;72(28):15740-15754. doi: 10.1021/acs.jafc.4c03286. Epub 2024 Jul 6.
4
Regulation of SIRT1-TLR2/TLR4 pathway in cell communication from macrophages to hepatic stellate cells contribute to alleviates hepatic fibrosis by Luteoloside.木犀草苷通过调控巨噬细胞与肝星状细胞之间细胞通讯中的SIRT1-TLR2/TLR4通路来减轻肝纤维化。
Acta Histochem. 2023 Jan;125(1):151989. doi: 10.1016/j.acthis.2022.151989. Epub 2022 Dec 16.
5
Astilbin alleviates hepatic fibrosis through PXR-PINK1/Parkin pathway: A new strategy by regulating hepatic stellate cells-macrophage crosstalk.紫云英苷通过 PXR-PINK1/Parkin 通路减轻肝纤维化:调控肝星状细胞-巨噬细胞相互作用的新策略。
Phytomedicine. 2024 Dec;135:156144. doi: 10.1016/j.phymed.2024.156144. Epub 2024 Oct 9.
6
Specnuezhenide ameliorates hepatic fibrosis via regulating SIRT6-Mediated inflammatory signaling cascades.参芪扶正注射液通过调节 SIRT6 介导的炎症信号级联反应改善肝纤维化。
J Ethnopharmacol. 2024 Dec 5;335:118646. doi: 10.1016/j.jep.2024.118646. Epub 2024 Aug 2.
7
Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.细胞外ATP对肝星状细胞激活的增强作用依赖于P2X7R介导的NLRP3炎性小体激活。
Pharmacol Res. 2017 Mar;117:82-93. doi: 10.1016/j.phrs.2016.11.040. Epub 2016 Dec 8.
8
Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.通过激活肝 X 受体(LXR)抑制肾移植慢性损伤:巨噬细胞 LXRα的相关作用
Am J Pathol. 2011 Jul;179(1):92-103. doi: 10.1016/j.ajpath.2011.03.019. Epub 2011 May 5.
9
P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells.P2X7R 通过形成从巨噬细胞到肝星状细胞的反馈回路来调控小鼠肝纤维化的进展。
Toxicol Lett. 2020 Oct 15;333:22-32. doi: 10.1016/j.toxlet.2020.07.023. Epub 2020 Jul 25.
10
Thioacetamide-Induced Norepinephrine Production by Hepatocytes is Associated with Hepatic Stellate Cell Activation and Liver Fibrosis.硫代乙酰胺诱导的肝细胞去甲肾上腺素产生与肝星状细胞激活和肝纤维化有关。
Curr Mol Pharmacol. 2022;15(2):454-461. doi: 10.2174/1874467214666210412144416.

引用本文的文献

1
Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives.探索肝星状细胞驱动的纤维化:治疗进展与未来展望
ADMET DMPK. 2025 Aug 4;13(4):2874. doi: 10.5599/admet.2874. eCollection 2025.
2
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
3
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease.
释放治疗潜力:探索新兴核受体之间的相互作用以对抗脂肪性肝病中的代谢功能障碍。
NPJ Metab Health Dis. 2024 Jul 3;2(1):13. doi: 10.1038/s44324-024-00013-6.
4
The role of mitophagy in metabolic diseases and its exercise intervention.线粒体自噬在代谢性疾病中的作用及其运动干预
Front Physiol. 2024 Jan 29;15:1339128. doi: 10.3389/fphys.2024.1339128. eCollection 2024.